GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (TSXV:SBM) » Definitions » EV-to-Revenue

Sirona Biochem (TSXV:SBM) EV-to-Revenue : 474.11 (As of May. 15, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Sirona Biochem EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sirona Biochem's enterprise value is C$17.54 Mil. Sirona Biochem's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 was C$0.04 Mil. Therefore, Sirona Biochem's EV-to-Revenue for today is 474.11.

The historical rank and industry rank for Sirona Biochem's EV-to-Revenue or its related term are showing as below:

TSXV:SBM' s EV-to-Revenue Range Over the Past 10 Years
Min: 11.2   Med: 78.06   Max: 506.37
Current: 474.11

During the past 13 years, the highest EV-to-Revenue of Sirona Biochem was 506.37. The lowest was 11.20. And the median was 78.06.

TSXV:SBM's EV-to-Revenue is ranked worse than
91.91% of 1038 companies
in the Biotechnology industry
Industry Median: 7.97 vs TSXV:SBM: 474.11

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-15), Sirona Biochem's stock price is C$0.06. Sirona Biochem's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 was C$0.00. Therefore, Sirona Biochem's PS Ratio for today is .


Sirona Biochem EV-to-Revenue Historical Data

The historical data trend for Sirona Biochem's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem EV-to-Revenue Chart

Sirona Biochem Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 725.19 530.96 176.44 48.77 661.96

Sirona Biochem Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.96 47.41 327.46 661.96 745.82

Competitive Comparison of Sirona Biochem's EV-to-Revenue

For the Biotechnology subindustry, Sirona Biochem's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sirona Biochem's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sirona Biochem's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sirona Biochem's EV-to-Revenue falls into.



Sirona Biochem EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sirona Biochem's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=17.542/0.037
=474.11

Sirona Biochem's current Enterprise Value is C$17.54 Mil.
Sirona Biochem's Revenue for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sirona Biochem  (TSXV:SBM) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sirona Biochem's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.06/0
=

Sirona Biochem's share price for today is C$0.06.
Sirona Biochem's Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sirona Biochem EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sirona Biochem's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sirona Biochem (TSXV:SBM) Business Description

Traded in Other Exchanges
Address
C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L3
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.

Sirona Biochem (TSXV:SBM) Headlines